ArticleJournal of human genetics2026
Expanding genetic and clinical spectra of β-tubulinopathies: A Korean study.
Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Role of Prenatal Neurosonography in Identification of Tubulinopathy-Narrative Review.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tubulin proteins form microtubules, which are critical for neuronal cell migration. In humans, there are at least 27 tubulin genes. Pathogenic variants in these genes cause tubulinopathies, which are characterized by diverse neurodevelopmental symptoms and brain malformations. This study analyzed the genetic variants and clinical characteristics of 12 patients (3 males, 9 females) with confirmed β-tubulinopathies. A retrospective chart review indicated that diagnoses were made via exome, genome, or targeted next-generation panel sequencing. Most patients (11/12) showed significant developmental delay and hypotonia. Other neurological symptoms included ocular motility disorders (7/12), ataxia (6/12), seizures (3/12), and microcephaly (2/12). The median age at symptom onset was 10 months (range 0 - 24). Corpus callosum abnormalities were the most common brain malformation, present in 10 patients, including one case of complete agenesis. Basal ganglia abnormalities and cerebellar hypoplasia were each observed in 9 patients. Cortical abnormalities, white matter changes, and brainstem hypoplasia were each present in 8 patients. Severe lissencephaly was not observed. Ten pathogenic or likely pathogenic missense variants were identified in five β-tubulin genes (TUBB2A, TUBB2B, TUBB3, TUBB4A, and TUBB5). Most variants were de novo, but one was a maternally inherited variant, c.211 G > A in TUBB3, which was associated with milder features. A novel variant in TUBB2A, c.1234 G > A p.(Glu412Lys), was also identified. These genetic variations were associated with a broad phenotypic spectrum of β-tubulinopathies, including complex brain malformations and neurodevelopmental disorders. Despite its rarity, tubulinopathy may be considered in the differential diagnosis for patients presenting with developmental delay and brain malformations.
Indexed as
Identifiers
41152456What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.